{"id":"NCT03170518","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus","officialTitle":"A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (â‰¥10 to <18 Years) With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-21","primaryCompletion":"2023-09-20","completion":"2023-09-20","firstPosted":"2017-05-31","resultsPosted":"2025-03-12","lastUpdate":"2025-04-25"},"enrollment":171,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Canagliflozin 100 mg","otherNames":["JNJ-28431754"]},{"type":"DRUG","name":"Canagliflozin 300 mg","otherNames":["JNJ-28431754"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Single-blind run-in Period: Placebo","type":"EXPERIMENTAL"},{"label":"Double-blind Treatment Phase: Canagliflozin or Placebo","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after 26 weeks of treatment, and to assess the overall safety and tolerability of canagliflozin.","primaryOutcome":{"measure":"Change From Baseline in Glycated Hemoglobin (HbA1c) at Week 26","timeFrame":"Baseline (Day 1) and Week 26","effectByArm":[{"arm":"Placebo","deltaMin":0.39,"sd":0.191},{"arm":"Canagliflozin 100/300 mg","deltaMin":-0.37,"sd":0.194}],"pValues":[{"comp":"OG000 vs OG001","p":"= 0.002"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":106,"countries":["United States","Brazil","China","Greece","India","Malaysia","Mexico","Philippines","Poland","Russia"]},"refs":{"pmids":["40759025"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":87},"commonTop":["Upper Respiratory Tract Infection","Upper Respiratory Tract Infection","Nasopharyngitis","Nasopharyngitis","Headache"]}}